论文部分内容阅读
目的观察参松养心胶囊治疗阵发性房颤的临床疗效。方法 100例患者随机分成参松组和对照组,各50例,均接受常规治疗,参松组在此基础上加用参松养心胶囊,6个月后进行临床评价。结果治疗后对照组患者房颤发作频率[(10.9±3.4)次/周]与治疗前[(12.1±3.1)次/周]比较差异无统计学意义(P>0.05),参松组患者治疗后[(6.2±3.1)次/周]与治疗前[(11.7±2.9)次/周]及对照组治疗后比较,发作频率显著降低(P<0.05)。结论参松养心胶囊对阵发性房颤有较好的疗效。
Objective To observe the clinical efficacy of Shensong Yangxin Capsule in the treatment of paroxysmal atrial fibrillation. Methods One hundred patients were randomly divided into the control group and the control group, 50 cases in each group. The patients in the control group were treated with Shensongyangxin Capsule on the basis of this. The clinical evaluation was performed 6 months later. Results There was no significant difference in the frequency of atrial fibrillation between the control group [(10.9 ± 3.4) times / week and [12.1 ± 3.1] weeks / week before treatment] (P> 0.05) The frequency of seizure was significantly lower than that of the control group [(6.2 ± 3.1) / week] and [before treatment (11.7 ± 2.9) times / week] and after treatment in the control group (P <0.05). Conclusion Shensong Yang Xin Capsule on paroxysmal atrial fibrillation has a good effect.